Category: Pharmaceutical company
Quick infos Headquarters: Massachusetts, United States Trade prices Volume: Market Cap: 956.15M Prev closed: Open: 15.61 High: 15.89 Low: 15.03 52 week low: 15.03 52 week high: 73.02 Dividends: No Dividends Next ER: May 4, 2022 Before Market Opens
About the Company Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPRâCas9 gene editing technology. The company went public on 2 Feb 2016.
Earnings History Date EPS / Forecast Revenue / Forecast August 10, 2022 May 4, 2022 -0.74 / -0.77386.77M / 3.94MBeat! February 24, 2022 -0.61 / -0.712212.47M / 4.64MBeat! November 8, 2021 -0.57 / -0.81296.2M / 4.74MBeat! August 4, 2021 -0.81 / -0.8235379K / 6.03MBeat! view more
Historical Data Date Price Open High Low Vol Change ER May 4, 2022 15.81 14.35 15.94
13.72
1.69M 11.50% May 3, 2022 14.18 14.24 14.65
13.83
959.21K -0.63% May 2, 2022 14.27 13.25 14.29
13.03
1.70M 7.78% Apr 29, 2022 13.24 13.86 14.41
13.19
1.23M -4.95% Apr 28, 2022 13.93 13.84 14.08
12.90
1.98M 2.73% Apr 27, 2022 13.56 14.00 14.20
13.51
1.67M -2.87% Apr 26, 2022 13.96 14.99 15.46
13.93
1.99M -6.87% Apr 25, 2022 14.99 14.54 14.99
14.34
1.40M 2.74% Apr 22, 2022 14.59 14.40 14.92
14.37
1.69M 1.53% Apr 21, 2022 14.37 15.70 16.09
14.26
1.68M -6.51% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Editas Medicine Announces Favorable Decision from U.S. Patent and Trademark Office in CRISPR Patent Interference finance.yahoo.com Apr 26, 2022 4:01 pm The Journey To Rewrite Human DNA Is About To Get Wild, Thanks To These CRISPR Stocks investors.com Apr 26, 2022 3:56 pm
Will Editas Medicine (EDIT) Report Negative Earnings Next Week? What You Should Know finance.yahoo.com Apr 26, 2022 3:03 pm
Why Editas Medicine Stock Is Jumping Today fool.com Apr 26, 2022 12:52 pm
Editas Suddenly Terminates Chief Medical Officer Without An Explanation finance.yahoo.com Apr 26, 2022 12:40 pm
Editas (EDIT) to Report Q3 Earnings: What's in the Cards? finance.yahoo.com Apr 26, 2022 10:02 am
After Plunging 30.8% in 4 Weeks, Here's Why the Trend Might Reverse for Editas (EDIT) finance.yahoo.com Apr 26, 2022 10:00 am
10 Genomics Stocks in Cathie Woods Portfolio That Are Underperforming finance.yahoo.com Apr 26, 2022 9:54 am
Patent Ruling Is a Setback for Gene-Editing Firms Tied to Crispr Nobelists barrons.com Apr 26, 2022 8:55 am
Editas Medicine Announces Third Quarter 2021 Results and Business Updates finance.yahoo.com Apr 26, 2022 7:00 am
Editas Medicine Announces Fourth Quarter and Full Year 2021 Results and Business Updates finance.yahoo.com Apr 26, 2022 6:30 am
What Kind Of Investors Own Most Of Editas Medicine, Inc. (NASDAQ:EDIT)? finance.yahoo.com Apr 26, 2022 5:19 am
3 Ominous Reasons to Avoid This Biotech Pioneer fool.com Apr 19, 2022 6:20 am Editas Medicine stock falls ~8% after Baird cuts price target seekingalpha.com Apr 18, 2022 11:23 pm Editas Medicine appoints Dr. Gilmore O’Neill as President and CEO seekingalpha.com Apr 14, 2022 7:42 pm
Former Sarepta, Biogen exec joins Editas as CEO bizjournals.com Apr 14, 2022 2:11 pm Editas begins dosing pediatric patient in trial to treat eye disorder seekingalpha.com Apr 11, 2022 10:36 pm Intellia Therapeutics Crashes As Patent Decision Clouds CRISPR Gene-Editing Test investors.com Mar 1, 2022 4:36 pm
Editas' (EDIT) Q4 Loss Narrows, Revenues Trump Estimates finance.yahoo.com Feb 25, 2022 11:51 am
Prothena (PRTA) Reports Q4 Loss, Tops Revenue Estimates finance.yahoo.com Feb 17, 2022 5:45 pm This company doesn't provide a dividend.
Key Persons Talk about Editas below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 27 HOLD 45 SELL 27
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!